| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/16/2003 | EP0737069B1 Deuterised active agents in transdermal application |
| 04/16/2003 | CN1411508A Oligonucleotides modulating expression of enzymes involved in synthesis of melanic pigments |
| 04/16/2003 | CN1411458A Saccharin derivatives as orally active elastase inhibitors |
| 04/16/2003 | CN1411449A N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 04/16/2003 | CN1411447A Polymorphic crystalline forms of celecoxib |
| 04/16/2003 | CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 04/16/2003 | CN1411365A Cosmetic compositions containing mulberry extract and retinoids |
| 04/16/2003 | CN1411341A Reduced calorie fat compositions |
| 04/16/2003 | CN1411339A Antimicrobial composition comprising benzoic acid analog and metal salt |
| 04/16/2003 | CN1410413A Naprosyn precusor, its synthesis method and application |
| 04/16/2003 | CN1410122A Chinese medicine preparation for treating acute condyloma |
| 04/16/2003 | CN1410117A Liniment for treating purple patch wind |
| 04/16/2003 | CN1410116A Liniment for treating white patch wind |
| 04/16/2003 | CN1410107A Xiatare tablet and its preparation method |
| 04/16/2003 | CN1410106A Xiatare ointment and its preparation method |
| 04/16/2003 | CN1410103A Ointment for eliminating macula and its preparation method |
| 04/16/2003 | CN1410102A Ointment for eliminating macula and its preparation method |
| 04/16/2003 | CN1410086A Medicine for treating hoariness and alopecia |
| 04/16/2003 | CN1410072A Sulfadiazine silver chitinamine powder |
| 04/16/2003 | CN1410070A Acne cream |
| 04/16/2003 | CN1410068A Preparation method of water soluble tanshinone |
| 04/16/2003 | CN1410067A Chloromycetin kibe ointment |
| 04/16/2003 | CN1410052A Face mask for eliminating macula and whitening skin |
| 04/16/2003 | CN1410050A Multifunctional cosmetics |
| 04/16/2003 | CN1410046A Irony hair dyeing composition |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/16/2003 | CN1105705C Process for preparing heterocyclic amide derivative with specific physical status |
| 04/16/2003 | CN1105565C Drug for curing dermatosis and preparation method thereof |
| 04/16/2003 | CN1105561C Medicine for treating underarm odour and beriberi |
| 04/16/2003 | CN1105554C Skin care compositions containing combinations of compounds for mimicking effect on skin of retinoic acid |
| 04/15/2003 | WO2002089822A1 Bactericidal disinfectant, antibacterial drug, and antibacterial material |
| 04/15/2003 | US6548715 Which lacks the combined presence of the trans-fused ring; increased therapeutic potential; for cell proliferation; veterinary medicine |
| 04/15/2003 | US6548699 4,4*-(Isopropylidenedithio)-(2*,6*-di-tert-butylphenol)-(2,6-d i-tert-butylphenol-O*-acetic acid); antiarthritic, antiinflammatory agents; rheumatic and cardiovascular disorders |
| 04/15/2003 | US6548671 Quinoxalinyl amide derivatives |
| 04/15/2003 | US6548668 Stabilizer for proteins |
| 04/15/2003 | US6548638 Peptoid and nonpeptoid containing α-keto oxadiazoles as serine protease inhibitors |
| 04/15/2003 | US6548556 Stable enzymatic wound debrider |
| 04/15/2003 | US6548532 Topically applying onto the afflicted skin and/or scalp cosmetically/ therapeutically effective amount of indolecarboxylic acid compound, or ester or salt thereof |
| 04/15/2003 | US6548526 Isothiazole derivatives useful as anticancer agents |
| 04/15/2003 | US6548520 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/15/2003 | US6548514 Inhibitors of p38 kinase/cytokine suppressive binding protein (CSBP)/reactivating kinase (RK); 1-((pyridyl)aminocarbonyl)-3-((hetero)arylaminocarbonyl)benzene derivatives; treating cytokine related diseases and disorders |
| 04/15/2003 | US6548503 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 04/15/2003 | US6548500 Treating a cell adhesion-mediated diseases such as multiple sclerosis, asthma, atherosclerosis, rheumatoid arthritis, meningitis, comprising administering to a warm blooded animal a nitrogen atoms containing bicyclic compound |
| 04/15/2003 | US6548494 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases |
| 04/15/2003 | US6548483 Nutritional preparation comprising ribose and medical use thereof |
| 04/15/2003 | US6548270 An expression vector comprising a recombinant polynucleotide encoding a protein containing specific amino acid sequence; genetic engineering |
| 04/15/2003 | US6548077 Purifying type I collagen using two papain treatments and reducing and delipidation agents |
| 04/15/2003 | CA2426096A1 Sterilizing disinfectant, antimicrobial agent and antimicrobial material |
| 04/15/2003 | CA2051504C 1-phenyl-3-aryl-2-propyne-1-ones as calcium uptake inhibitors |
| 04/15/2003 | CA2048242C 4-amino-4-steroids and their use as 5.alpha.-reductase inhibitors |
| 04/15/2003 | CA2037975C 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors |
| 04/11/2003 | WO2002030934A1 Substituted 3.4-dihydro-pyrimido[1,2-a]pyrimidines and 3.4-dihydropyrazino[1,2-a]pyrimidines |
| 04/11/2003 | CA2425685A1 Substituted 3.4-dihydro-pyrimido[1,2-a]pyrimidines and 3.4-dihydropyrazino[1,2-a]pyrimidines |
| 04/10/2003 | WO2003029437A2 Secreted proteins |
| 04/10/2003 | WO2003029424A2 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy |
| 04/10/2003 | WO2003029276A2 Copolymers for suppression of autoimmune diseases, and methods of use |
| 04/10/2003 | WO2003029269A1 Solvent extraction process |
| 04/10/2003 | WO2003029250A1 Benzisothiazolyl-substituted aminomethyl chromanes for treating diseases of the central nervous system |
| 04/10/2003 | WO2003029248A1 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl) -n-phenylamines as antiproliferative compounds |
| 04/10/2003 | WO2003029245A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/10/2003 | WO2003029242A1 NF-λB INHIBITORS |
| 04/10/2003 | WO2003029205A1 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
| 04/10/2003 | WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
| 04/10/2003 | WO2003029187A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 04/10/2003 | WO2003029184A1 Diaryl ether derivative, addition salt thereof, and immunosuppressant |
| 04/10/2003 | WO2003028759A1 Rsv gene expression vaccine |
| 04/10/2003 | WO2003028749A1 Matrix metalloprotease inhibitor |
| 04/10/2003 | WO2003028744A1 Process for producing collagen production enhancers and use thereof |
| 04/10/2003 | WO2003028743A1 Storage-stable fibrinogen solutions |
| 04/10/2003 | WO2003028742A1 Strontium compound for treatment of sub-dermal soft tissue pain |
| 04/10/2003 | WO2003028741A1 Composition of hypochlorous acid and its applications |
| 04/10/2003 | WO2003028740A1 Compositions for the treatment of pilosebaceous gland inflammations comprising aluminium fluoride |
| 04/10/2003 | WO2003028715A2 Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis |
| 04/10/2003 | WO2003028713A2 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 04/10/2003 | WO2003028712A2 Purinergic and pyrimidinergic receptor agonists for the treatment of activated cd4+ t lymphocyte-mediated immune diseases |
| 04/10/2003 | WO2003028705A1 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 04/10/2003 | WO2003028692A2 Acne treatment using oleanolic acid |
| 04/10/2003 | WO2003028674A2 Method for stimulating hair growth by administering vitamin d analogs |
| 04/10/2003 | WO2003028673A1 Cosmetic preparation |
| 04/10/2003 | WO2003028654A2 Storage-stable human fibrinogen solutions |
| 04/10/2003 | WO2003028630A2 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/10/2003 | WO2003017935A9 Human antibodies specific for interleukin 15 (il-15) |
| 04/10/2003 | WO2003004527A3 Novel neurotrophic factors |
| 04/10/2003 | WO2003004493A8 Novel compounds, their preparation and use |
| 04/10/2003 | WO2003002086A3 Use of the tripeptide lys-pro-val(kpv) for improving the skin barrier function |
| 04/10/2003 | WO2002102394A3 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 04/10/2003 | WO2002094189A3 Compositions and methods for treating or preventing convulsions or seizures |
| 04/10/2003 | WO2002092064A3 Therapeutic method for inducing tolerance |
| 04/10/2003 | WO2002081668A8 Desaturase genes and uses thereof |
| 04/10/2003 | WO2002076408A3 Use of creatine, creatinine and/or derivatives thereof |
| 04/10/2003 | WO2002071827A3 Retinoid x receptor modulators |
| 04/10/2003 | WO2002059083A3 Novel compounds |
| 04/10/2003 | WO2002055705A3 Proteins and nucleic acids encoding same |
| 04/10/2003 | WO2002050122A3 Means for the diagnosis and therapy of ctcl |
| 04/10/2003 | WO2002043745A3 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma |
| 04/10/2003 | WO2002040666A3 Fat regulated genes, uses thereof, and compounds for modulating same |
| 04/10/2003 | WO2002008396A3 Human proteases |
| 04/10/2003 | US20030069435 Prevention of neutrophil recruitment |